Clinical Trial Update: Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial investigating increased GABAergic activity for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Manitoba | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: WITHDRAWN